Journey Medical Corp (DERM)
3.93
+0.13
(+3.42%)
USD |
NASDAQ |
May 31, 16:00
3.93
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Gross Profit (Quarterly): 6.214M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.214M |
December 31, 2023 | 9.242M |
September 30, 2023 | 28.11M |
June 30, 2023 | 9.405M |
March 31, 2023 | 5.764M |
December 31, 2022 | 8.248M |
September 30, 2022 | 8.895M |
June 30, 2022 | 10.66M |
Date | Value |
---|---|
March 31, 2022 | 15.09M |
December 31, 2021 | 7.992M |
September 30, 2021 | 8.443M |
June 30, 2021 | 7.804M |
March 31, 2021 | 6.811M |
December 31, 2020 | 9.442M |
September 30, 2020 | 6.068M |
June 30, 2020 | 6.291M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
5.764M
Minimum
Mar 2023
28.11M
Maximum
Sep 2023
9.655M
Average
8.346M
Median
Gross Profit (Quarterly) Benchmarks
Fortress Biotech Inc | 6.214M |
Stereotaxis Inc | 3.966M |
GT Biopharma Inc | -- |
Cara Therapeutics Inc | 1.515M |
FibroGen Inc | 30.15M |